178 related articles for article (PubMed ID: 7560165)
1. Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p.
Lakhani SR; Collins N; Stratton MR; Sloane JP
J Clin Pathol; 1995 Jul; 48(7):611-5. PubMed ID: 7560165
[TBL] [Abstract][Full Text] [Related]
2. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
Radford DM; Fair KL; Phillips NJ; Ritter JH; Steinbrueck T; Holt MS; Donis-Keller H
Cancer Res; 1995 Aug; 55(15):3399-405. PubMed ID: 7614479
[TBL] [Abstract][Full Text] [Related]
3. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium.
Moinfar F; Man YG; Bratthauer GL; Ratschek M; Tavassoli FA
Cancer; 2000 May; 88(9):2072-81. PubMed ID: 10813719
[TBL] [Abstract][Full Text] [Related]
4. Pattern of chromosome 16q loss differs between an atypical proliferative lesion and an intraductal or invasive ductal carcinoma occurring subsequently in the same area of the breast.
Tsuda H; Takarabe T; Akashi-Tanaka S; Fukutomi T; Hirohashi S
Mod Pathol; 2001 May; 14(5):382-8. PubMed ID: 11353046
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors.
Larson PS; de las Morenas A; Cerda SR; Bennett SR; Cupples LA; Rosenberg CL
J Pathol; 2006 Jul; 209(3):307-16. PubMed ID: 16604511
[TBL] [Abstract][Full Text] [Related]
6. Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization.
Gong G; DeVries S; Chew KL; Cha I; Ljung BM; Waldman FM
Clin Cancer Res; 2001 Aug; 7(8):2410-4. PubMed ID: 11489820
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity in ductal carcinoma in situ of the breast.
Stratton MR; Collins N; Lakhani SR; Sloane JP
J Pathol; 1995 Feb; 175(2):195-201. PubMed ID: 7738715
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal alterations in pure nonneoplastic breast lesions: implications for breast cancer progression.
Ellsworth RE; Ellsworth DL; Weyandt JD; Fantacone-Campbell JL; Deyarmin B; Hooke JA; Shriver CD
Ann Surg Oncol; 2010 Jun; 17(6):1688-94. PubMed ID: 20107913
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction.
Nayar R; Zhuang Z; Merino MJ; Silverberg SG
Hum Pathol; 1997 Mar; 28(3):277-82. PubMed ID: 9042790
[TBL] [Abstract][Full Text] [Related]
10. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region.
Chen T; Sahin A; Aldaz CM
Cancer Res; 1996 Dec; 56(24):5605-9. PubMed ID: 8971163
[TBL] [Abstract][Full Text] [Related]
11. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.
Chuaqui RF; Zhuang Z; Emmert-Buck MR; Liotta LA; Merino MJ
Am J Pathol; 1997 Jan; 150(1):297-303. PubMed ID: 9006344
[TBL] [Abstract][Full Text] [Related]
12. LOH analyses of premalignant and malignant lesions of human breast: frequent LOH in 8p, 16q, and 17q in atypical ductal hyperplasia.
Amari M; Suzuki A; Moriya T; Yoshinaga K; Amano G; Sasano H; Ohuchi N; Satomi S; Horii A
Oncol Rep; 1999; 6(6):1277-80. PubMed ID: 10523696
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity and allelic imbalance in apocrine metaplasia of the breast: microdissection microsatellite analysis.
Selim AG; Ryan A; El-Ayat G; Wells CA
J Pathol; 2002 Mar; 196(3):287-91. PubMed ID: 11857491
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity and microsatellite instability in epithelial hyperplasia of the breast.
Kaneko M; Arihiro K; Takeshima Y; Fujii S; Inai K
J Exp Ther Oncol; 2002; 2(1):9-18. PubMed ID: 12415615
[TBL] [Abstract][Full Text] [Related]
16. Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers.
Dorion-Bonnet F; Mautalen S; Hostein I; Longy M
Genes Chromosomes Cancer; 1995 Nov; 14(3):171-81. PubMed ID: 8589033
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity in lobular carcinoma in situ of the breast.
Lakhani SR; Collins N; Sloane JP; Stratton MR
Clin Mol Pathol; 1995 Apr; 48(2):M74-8. PubMed ID: 16695985
[TBL] [Abstract][Full Text] [Related]
18. [Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions].
Fu Q; Yao GY; Tang XL; Chen LR; Zheng ZX
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):34-40. PubMed ID: 17575691
[TBL] [Abstract][Full Text] [Related]
19. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.
O'Connell P; Pekkel V; Fuqua SA; Osborne CK; Clark GM; Allred DC
J Natl Cancer Inst; 1998 May; 90(9):697-703. PubMed ID: 9586667
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer.
Aubele MM; Cummings MC; Mattis AE; Zitzelsberger HF; Walch AK; Kremer M; Höfler H; Werner M
Diagn Mol Pathol; 2000 Mar; 9(1):14-9. PubMed ID: 10718208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
